Laboratorio Reig Jofre, S.A.
MCE RJF.MC
Laboratorio Reig Jofre, S.A. Price to Earnings Ratio (P/E) on January 14, 2025: 19.95
-
Laboratorio Reig Jofre, S.A. 52-week high Price to Earnings Ratio (P/E) is 25.36 on October 14, 2024, which is 27.13% above the current Price to Earnings Ratio (P/E).
-
Laboratorio Reig Jofre, S.A. 52-week low Price to Earnings Ratio (P/E) is 17.91 on February 21, 2024, which is -10.24% below the current Price to Earnings Ratio (P/E).
-
Laboratorio Reig Jofre, S.A. average Price to Earnings Ratio (P/E) for the last 52 weeks is 21.25.
| Date | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) | Dividend Yield |
|---|
| CEO | Mr. Ignasi Biosca Reig |
| IPO Date | Nov. 29, 2002 |
| Location | Spain |
| Headquarters | Gran Capita, 10 |
| Employees | 1,331 |
| Sector | Health Care |
| Industries | |
Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products and food supplements. The company offers prescription medicines, OTCs, medical devices, and cosmetics. Its products include pharmaceutical technologies products, such as antibiotics, and injectable and other products; specialty pharmacare products, which include skin, hair, and nail health, joint health and pain, women's health, respiratory/ENT, and pediatrics; and consumer healthcare products under the Forté Pharma brand. The company also provides CDMO and CMO services. It sells its products directly in 7 countries and through business partners in approximately 70 countries. The company was founded in 1929 and is based in Sant Joan Despí, Spain. Laboratorio Reig Jofre, S.A. is a subsidiary of Reig Jofre Investments SL.
Past 5 years
USD 77.86
USD 59.78
USD 3.46
USD 8.60
USD 1.51
StockViz Staff
January 15, 2025
Any question? Send us an email